vs
Essex Property Trust（ESS）与和黄医药（HCM）财务数据对比。点击上方公司名可切换其他公司
Essex Property Trust的季度营收约是和黄医药的1.8倍（$479.6M vs $270.8M），Essex Property Trust净利率更高（17.9% vs 0.7%，领先17.2%），Essex Property Trust同比增速更快（5.5% vs -16.5%）
Essex Property Trust是一家公开上市的房地产投资信托企业，重点布局美国西海岸优质不动产市场，核心投资标的为加利福尼亚州及西雅图大都会区的公寓类物业，在长租公寓的投资、运营及管理领域拥有深厚的行业积累与资源优势。
和黄医药是一家国际化生物制药企业，专注于肿瘤、免疫类疾病的靶向疗法与免疫疗法的研发、生产及商业化，核心市场覆盖中国及全球多个国家地区，已有多款肿瘤治疗药物上市，后期临床管线储备丰富。
ESS vs HCM — 直观对比
营收规模更大
ESS
是对方的1.8倍
$270.8M
营收增速更快
ESS
高出22.1%
-16.5%
净利率更高
ESS
高出17.2%
0.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $479.6M | $270.8M |
| 净利润 | $85.7M | $2.0M |
| 毛利率 | 70.0% | 37.7% |
| 营业利润率 | 31.7% | -13.2% |
| 净利率 | 17.9% | 0.7% |
| 营收同比 | 5.5% | -16.5% |
| 净利润同比 | -71.6% | -83.6% |
| 每股收益（稀释后） | $1.24 | $0.00 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ESSHCM
| Q4 25 | $479.6M | $270.8M | ||
| Q3 25 | $473.3M | — | ||
| Q2 25 | $469.8M | $277.7M | ||
| Q1 25 | $464.6M | $324.5M | ||
| Q4 24 | $454.5M | — | ||
| Q3 24 | $450.7M | — | ||
| Q2 24 | $442.4M | $305.7M | ||
| Q1 24 | $426.9M | — |
净利润ESSHCM
| Q4 25 | $85.7M | $2.0M | ||
| Q3 25 | $172.7M | — | ||
| Q2 25 | $231.5M | $455.0M | ||
| Q1 25 | $212.8M | $11.9M | ||
| Q4 24 | $301.7M | — | ||
| Q3 24 | $125.5M | — | ||
| Q2 24 | $99.0M | $25.8M | ||
| Q1 24 | $285.1M | — |
毛利率ESSHCM
| Q4 25 | 70.0% | 37.7% | ||
| Q3 25 | 69.2% | — | ||
| Q2 25 | 70.7% | 0.1% | ||
| Q1 25 | 69.6% | 48.0% | ||
| Q4 24 | 70.0% | — | ||
| Q3 24 | 69.5% | — | ||
| Q2 24 | 70.8% | 41.1% | ||
| Q1 24 | 69.7% | — |
营业利润率ESSHCM
| Q4 25 | 31.7% | -13.2% | ||
| Q3 25 | 44.5% | — | ||
| Q2 25 | 59.5% | -1.3% | ||
| Q1 25 | 55.3% | -5.0% | ||
| Q4 24 | 67.0% | — | ||
| Q3 24 | 28.6% | — | ||
| Q2 24 | 31.1% | -9.0% | ||
| Q1 24 | 31.0% | — |
净利率ESSHCM
| Q4 25 | 17.9% | 0.7% | ||
| Q3 25 | 36.5% | — | ||
| Q2 25 | 49.3% | 163.8% | ||
| Q1 25 | 45.8% | 3.7% | ||
| Q4 24 | 66.4% | — | ||
| Q3 24 | 27.8% | — | ||
| Q2 24 | 22.4% | 8.4% | ||
| Q1 24 | 66.8% | — |
每股收益（稀释后）ESSHCM
| Q4 25 | $1.24 | $0.00 | ||
| Q3 25 | $2.56 | — | ||
| Q2 25 | $3.44 | $0.52 | ||
| Q1 25 | $3.16 | $0.01 | ||
| Q4 24 | $4.00 | — | ||
| Q3 24 | $1.84 | — | ||
| Q2 24 | $1.45 | $0.03 | ||
| Q1 24 | $4.25 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $76.2M | $1.4B |
| 总债务越低越好 | — | $93.2M |
| 股东权益账面价值 | $5.5B | $1.2B |
| 总资产 | $13.2B | $1.8B |
| 负债/权益比越低杠杆越低 | — | 0.08× |
8季度趋势，按日历期对齐
现金及短期投资ESSHCM
| Q4 25 | $76.2M | $1.4B | ||
| Q3 25 | $66.0M | — | ||
| Q2 25 | $58.7M | $1.4B | ||
| Q1 25 | $98.7M | $836.1M | ||
| Q4 24 | $66.8M | — | ||
| Q3 24 | $71.3M | — | ||
| Q2 24 | $55.2M | $802.5M | ||
| Q1 24 | $499.0M | — |
总债务ESSHCM
| Q4 25 | — | $93.2M | ||
| Q3 25 | $6.4B | — | ||
| Q2 25 | $6.4B | $93.4M | ||
| Q1 25 | $6.8B | $82.8M | ||
| Q4 24 | — | — | ||
| Q3 24 | $6.4B | — | ||
| Q2 24 | $6.2B | $82.1M | ||
| Q1 24 | $6.6B | — |
股东权益ESSHCM
| Q4 25 | $5.5B | $1.2B | ||
| Q3 25 | $5.6B | — | ||
| Q2 25 | $5.6B | $1.2B | ||
| Q1 25 | $5.6B | $759.9M | ||
| Q4 24 | $5.5B | — | ||
| Q3 24 | $5.4B | — | ||
| Q2 24 | $5.5B | $740.1M | ||
| Q1 24 | $5.5B | — |
总资产ESSHCM
| Q4 25 | $13.2B | $1.8B | ||
| Q3 25 | $13.2B | — | ||
| Q2 25 | $13.2B | $1.8B | ||
| Q1 25 | $13.2B | $1.3B | ||
| Q4 24 | $12.9B | — | ||
| Q3 24 | $12.6B | — | ||
| Q2 24 | $12.5B | $1.3B | ||
| Q1 24 | $12.9B | — |
负债/权益比ESSHCM
| Q4 25 | — | 0.08× | ||
| Q3 25 | 1.15× | — | ||
| Q2 25 | 1.14× | 0.08× | ||
| Q1 25 | 1.22× | 0.11× | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | 1.13× | 0.11× | ||
| Q1 24 | 1.19× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.1B | $8.2M |
| 自由现金流经营现金流 - 资本支出 | — | $3.4M |
| 自由现金流率自由现金流/营收 | — | 1.2% |
| 资本支出强度资本支出/营收 | — | 1.8% |
| 现金转化率经营现金流/净利润 | 12.53× | 4.21× |
| 过去12个月自由现金流最近4个季度 | — | $-96.2M |
8季度趋势，按日历期对齐
经营现金流ESSHCM
| Q4 25 | $1.1B | $8.2M | ||
| Q3 25 | $342.6M | — | ||
| Q2 25 | $216.1M | $-72.9M | ||
| Q1 25 | $281.5M | $40.3M | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $316.2M | — | ||
| Q2 24 | $218.9M | $-39.8M | ||
| Q1 24 | $314.9M | — |
自由现金流ESSHCM
| Q4 25 | — | $3.4M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $-82.2M | ||
| Q1 25 | — | $32.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | $-49.9M | ||
| Q1 24 | — | — |
自由现金流率ESSHCM
| Q4 25 | — | 1.2% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | -29.6% | ||
| Q1 25 | — | 10.0% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -16.3% | ||
| Q1 24 | — | — |
资本支出强度ESSHCM
| Q4 25 | — | 1.8% | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 3.3% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 3.3% | ||
| Q1 24 | — | — |
现金转化率ESSHCM
| Q4 25 | 12.53× | 4.21× | ||
| Q3 25 | 1.98× | — | ||
| Q2 25 | 0.93× | -0.16× | ||
| Q1 25 | 1.32× | 3.38× | ||
| Q4 24 | 3.54× | — | ||
| Q3 24 | 2.52× | — | ||
| Q2 24 | 2.21× | -1.54× | ||
| Q1 24 | 1.10× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
